N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine

C124H109N29O3S — CID 161387050

About N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine

N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine (PubChem CID 161387050) has the molecular formula C124H109N29O3S and a molecular weight of 2085.50 g/mol. Its IUPAC name is N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine.

Molecular Properties

• Compound Name: N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine
• PubChem CID: 161387050
• Molecular Formula: C124H109N29O3S
• Molecular Weight: 2085.50 g/mol
• Exact Mass: 2083.90
• IUPAC Name: N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine
• SMILES: Cc1cc(-c2cc3ccnc(NCc4ccc(-c5ccnnc5)cc4)c3cn2)ccn1.Cc1cc(-c2cc3ccnc(NCc4ccc(N5CCS(=O)(=O)CC5)nc4)c3cn2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5ccnnc5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5cnccn5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(N5CCOCC5)ncc34)cc2)ccn1
• InChI: InChI=1S/3C25H20N6.C25H25N5O.C24H24N6O2S/c1-17-12-21(7-9-26-17)24-13-20-6-10-27-25(23(20)16-28-24)29-14-18-2-4-19(5-3-18)22-8-11-30-31-15-22;1-17-12-20(6-9-26-17)19-4-2-18(3-5-19)14-29-25-23-16-28-24(13-21(23)7-10-27-25)22-8-11-30-31-15-22;1-17-12-20(6-8-27-17)19-4-2-18(3-5-19)14-31-25-22-15-30-23(13-21(22)7-9-29-25)24-16-26-10-11-28-24;1-18-14-21(6-8-26-18)20-4-2-19(3-5-20)16-29-25-23-17-28-24(15-22(23)7-9-27-25)30-10-12-31-13-11-30;1-17-12-20(5-6-25-17)22-13-19-4-7-26-24(21(19)16-27-22)29-15-18-2-3-23(28-14-18)30-8-10-33(31,32)11-9-30/h2*2-13,15-16H,14H2,1H3,(H,27,29);2-13,15-16H,14H2,1H3,(H,29,31);2-9,14-15,17H,10-13,16H2,1H3,(H,27,29);2-7,12-14,16H,8-11,15H2,1H3,(H,26,29)
• InChIKey: VSMHZKYHJBSGHV-UHFFFAOYSA-N
• XLogP: 22.90
• TPSA: 393.58 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 32
• Rotatable Bonds: 25
• Heavy Atoms: 157
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2085.50
LogP ≤ 5	22.90
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	32

Frequently Asked Questions

What is the IUPAC name of N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine?

The IUPAC name of N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine (CID 161387050) is N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine.

What is the SMILES notation for N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine?

The canonical SMILES for N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine is Cc1cc(-c2cc3ccnc(NCc4ccc(-c5ccnnc5)cc4)c3cn2)ccn1.Cc1cc(-c2cc3ccnc(NCc4ccc(N5CCS(=O)(=O)CC5)nc4)c3cn2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5ccnnc5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5cnccn5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(N5CCOCC5)ncc34)cc2)ccn1.

What is the InChIKey of N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine?

The InChIKey is VSMHZKYHJBSGHV-UHFFFAOYSA-N. The full InChI is InChI=1S/3C25H20N6.C25H25N5O.C24H24N6O2S/c1-17-12-21(7-9-26-17)24-13-20-6-10-27-25(23(20)16-28-24)29-14-18-2-4-19(5-3-18)22-8-11-30-31-15-22;1-17-12-20(6-9-26-17)19-4-2-18(3-5-19)14-29-25-23-16-28-24(13-21(23)7-10-27-25)22-8-11-30-31-15-22;1-17-12-20(6-8-27-17)19-4-2-18(3-5-19)14-31-25-22-15-30-23(13-21(22)7-9-29-25)24-16-26-10-11-28-24;1-18-14-21(6-8-26-18)20-4-2-19(3-5-20)16-29-25-23-17-28-24(15-22(23)7-9-27-25)30-10-12-31-13-11-30;1-17-12-20(5-6-25-17)22-13-19-4-7-26-24(21(19)16-27-22)29-15-18-2-3-23(28-14-18)30-8-10-33(31,32)11-9-30/h2*2-13,15-16H,14H2,1H3,(H,27,29);2-13,15-16H,14H2,1H3,(H,29,31);2-9,14-15,17H,10-13,16H2,1H3,(H,27,29);2-7,12-14,16H,8-11,15H2,1H3,(H,26,29).

What are the key properties of N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine?

N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine has a molecular weight of 2085.50 g/mol, XLogP of 22.90, 25 rotatable bonds, 5 hydrogen bond donors, and 32 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[6-(1,1-dioxo-1,4-thiazinan-4-yl)-3-pyridinyl]methyl]-6-(2-methyl-4-pyridinyl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-morpholin-4-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyrazin-2-yl-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-pyridazin-4-yl-2,7-naphthyridin-1-amine;6-(2-methyl-4-pyridinyl)-N-[(4-pyridazin-4-ylphenyl)methyl]-2,7-naphthyridin-1-amine is sourced from PubChem (CID 161387050), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).